690 Compliance To Antiplatelet Treatment In Post Myocardial Infarction Patients In Primary Care In Greece

Conference: 
Author(s): 
Alevizos Alevizos - Health Centre of Vyronas, Athens, Greece
C. Mihas - Health Centre of Vyronas, Athens, Greece
D. Fanou - Health Centre of Vyronas, Athens, Greece
G. Larios - Health Centre of Vyronas, Athens, Greece
M. Papathanassiou - Health Centre of Vyronas, Athens, Greece
A. Mariolis - Health Centre of Vyronas, Athens, Greece
Text: 
Poster
Aims: Antiplatelet therapy is effective in the primary and secondary prevention of Coronary Heart Disease (CHD). In the present study we aimed to investigate the extent of, as well as the main factors resulting in reduced compliance to antiplatelet treatment among patients with a history of myocardial infarction (MI), as encountered in a primary care health setting.
Design and Methods: The material of our study consisted in 178 patients (107 men, 71 women) aged 40 to 79 years that visited our Primary Health Care Unit. The inclusion criteria consisted in a positive history of MI, at least 12 months away before enrolment. All patients have been hospitalized upon MI and were prescribed antiplatelet therapy after discharge. Patients with a history of coronary surgery (CABG) were excluded from the study.
Results: Of the 178 participants, 137 (76.96%) were receiving aspirin, while 41 (23.04%) had discontinued antiplatelet therapy. The factors that positively influenced adherence to therapy were: BMI, total Cholesterol and LDL levels, diastolic blood pressure, smoking, length of stay in the CCU, educational status, marital status and number of children, history of PCI and previous history of MI.
Conclusions: The results of our study strongly indicate that there is a remarkably reduced adherence to antiplatelet (ASA) treatment in patients with a history of MI. Patients who underwent PCI were among the less affected, while greater reductions in compliance were observed especially in patients with silent MI and those without CCU hospitalization. In order to improve compliance to antiplatelet therapy, further research should investigate existing barriers and implement new methods of intervention.
Literature: 
690
COMPLIANCE TO ANTIPLATELET TREATMENT IN POST MYOCARDIAL INFARCTION PATIENTS IN PRIMARY CARE IN GREECE